Omega Therapeutics, Inc. is developing a new class of programmable epigenetic medicines known as Omega Epigenomic Controllers. Its OMEGA Epigenomic Programming platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cell genesis, growth, and differentiation to cell death. It has deciphered the three-dimensional architecture of the human genome and its accompanying regulators, which are organized into distinct and evolutionarily conserved structures called Insulated Genomic Domains. Omega Therapeutics was incorporated in 2016 and is headquartered in Cambridge, MA.
What is Omega Therapeutics's quote symbol?
What is the 52 week high and low for Omega Therapeutics (NASDAQ: OMGA)?
How much is Omega Therapeutics stock worth today?
How much is Omega Therapeutics's stock price per share?
What is Omega Therapeutics's Market Cap?